Cargando…

Approved Societies and Hospital Treatment

Mostrar otras versiones (2)

Detalles Bibliográficos
Autor principal:	Squires, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Press 1922
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517985/ https://www.ncbi.nlm.nih.gov/pubmed/29418225

Ejemplares similares

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Michelli, P. J.
Publicado: (1922)

Hospitals and Approved Societies
por: Dunstan, S.
Publicado: (1923)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Edinburgh Royal Infirmary and Approved Societies
por: Caw, Wm. S.
Publicado: (1922)

Do the Approved Societies Seek to Control the Doctors?
por: Ward, Gordon
Publicado: (1922)

Hospitals and the Approved Societies' Surplus
por: Lamb, S. R.
Publicado: (1921)

Contributions from Approved Societies to Hospitals
Publicado: (1913)

National Insurance. The Approved Societies and the Hospitals
Publicado: (1913)

Agreements between Approved Societies and Hospitals
Publicado: (1913)

Approved Societies in Relation to Voluntary Hospitals
por: Meller, R. J.
Publicado: (1924)

Section 12 approval: fit for purpose?
por: Gupta, Nidhi, et al.
Publicado: (2020)

Section 12 approval: fit for purpose?
por: Ballantyne-Watts, Darryl
Publicado: (2020)

Research approvals iceberg: helping it melt away
por: Kolstoe, Simon E., et al.
Publicado: (2019)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
por: Khan, Abdul Moiz, et al.
Publicado: (2023)

Section 12(2) MHA approval process is fit for purpose
por: Khwaja, Masum
Publicado: (2020)

Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022)

The Solvency of Approved Societies
Publicado: (1914)

Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults
por: Lambert, David, et al.
Publicado: (2020)

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

I-ACT for Children: helping close the gap in drug approval for adults and children
por: Coppes, Max J., et al.
Publicado: (2022)

The Approved Societies and Their Medical Referees
Publicado: (1913)

Approved Societies and District Nurses
Publicado: (1913)

Response to Correspondence from Kolstoe and colleagues concerning our paper entitled, Research approvals iceberg: How a ‘low-key’ study in England needed 89 professionals to approve it and how we can do better
por: Petrova, Mila, et al.
Publicado: (2019)

Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity
por: Núñez, Isaac
Publicado: (2022)

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)

Celebrating breakthrough in dental diagnostics: FDA approval of an AI model for diagnosis of periodontal diseases: A correspondence
por: Khan, Ayesha, et al.
Publicado: (2023)

Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence
por: Abbasi, Haleema Qayyum, et al.
Publicado: (2023)

Treatment Decisions for Unrepresented Patients: American Thoracic Society/American Geriatrics Society Policy Statement Lacks Sufficient Guidance
por: Weber, Eli
Publicado: (2020)

Letter comments on: “Twelve years of European cancer drug approval—a systematic investigation of the ‘magnitude of clinical benefit’”
por: Müller, B., et al.
Publicado: (2022)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

Reply to Weber: Treatment Decisions for Unrepresented Patients: American Thoracic Society/American Geriatrics Society Policy Statement Lacks Sufficient Guidance
por: Pope, Thaddeus M., et al.
Publicado: (2020)

Dental Societies
Publicado: (1882)

Research Defence Society
por: Marjoribanks, J. L.
Publicado: (1909)

Research Defence Society
por: Paget, Stephen
Publicado: (1911)

Massachusetts Dental Society
por: Harris, Edward N.
Publicado: (1867)

Iowa Dental Society
Publicado: (1872)

Action of Monroe County Medical Society, Regarding Publication of State Society Transactions
Publicado: (1873)

Cannot write session to /tmp/vufind_sessions/sess_85u70ko4qblgg7seeaj9ip7ehp